Vicente Cés Souza-Dantas

Dr. Vicente Cés Souza-Dantas

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RSRodrigo Serafim
Rodrigo Serafim
FDFelipe Dal-Pizzol
Felipe Dal-Pizzol
VSVicente Cés Souza-Dantas
Vicente Cés Souza-Dantas
MSMarcio Soares
Marcio Soares
FBFernando Bozza
Fernando Bozza
JSJorge I. F. Salluh
Jorge I. F. Salluh
Despite recent advances in the field, the association between subsyndromal delirium (SSD) in the ICU and poor outcomes is not entirely clear. We performed a retrospective multicentric observational study analyzing mental status during the first 72 h of ICU stay. Of the 681 patients included, SSD occurred in 22.7%. Considering the worst cognitive assessment during the first 72 h, 233 (34%) patients had normal mental status, 124 (18%) patients had SSD and 324 (48%) patients had delirium or coma. SSD was not independently associated with an increased risk of death when compared with normal mental status (OR 95%IC 1.0 vs. 1.35 [0.73–1.49], p = 0.340), but was associated with a longer ICU LOS (7.0 (4–12) vs. 4 (3–8) days, p < 0.001). SSD patients who deteriorated to delirium or coma (21%) had a longer ICU LOS in comparison with those who improved or maintained mental status (8 (5–11) vs. 6 (4–8) days, p = 0.025), but did not have an increase in mortality. The main factors associated with the progression from SSD to delirium or coma were the use of mechanical ventilation, the use of intravenous benzodiazepines and a baseline APACHE II score > 23 points. Our findings support the association of SSD with increased ICU LOS, but not with ICU mortality. Monitoring the trajectory of SSD early at ICU admission can help to identify patients with increased risk of conversion from SSD to delirium or coma.

1 January 2019 in Revista Brasileira de Terapia Intensiva
Verified
Journal Article
Open access
PDF file
JSJorge Ibrahin Figueira Salluh
Jorge Ibrahin Figueira Salluh
VSVicente Cés Souza-Dantas
Vicente Cés Souza-Dantas
Ignacio Martin-LoechesIgnacio Martin-Loeches
Ignacio Martin-Loeches
TLThiago Costa Lisboa
Thiago Costa Lisboa
LRLigia Sarmet Cunha Farah Rabello
Ligia Sarmet Cunha Farah Rabello
PPPedro Pã³Voa
Pedro Pã³Voa
Ventilator-associated lower respiratory tract infection is one of the most frequent complications in mechanically ventilated patients. Ventilator-associated tracheobronchitis has been considered a disease that does not warrant antibiotic treatment by the medical community for many years. In the last decade, several studies have shown that tracheobronchitis could be considered an intermediate process that leads to ventilator-associated pneumonia. Furthermore, ventilator-associated tracheobronchitis has a limited impact on overall mortality but shows a significant association with increased patient costs, length of stay, antibiotic use, and duration of mechanical ventilation. Although we still need clear evidence, especially concerning treatment modalities, the present study on ventilator-associated tracheobronchitis highlights that there are important impacts of including this condition in clinical management and epidemiological and infection surveillance.

3 January 2025 in Critical Care
Verified
Journal Article
Open access
PDF file
BTBruno Martins Tomazini
Bruno Martins Tomazini
BBBruno Adler Maccagnan Pinheiro Besen
Bruno Adler Maccagnan Pinheiro Besen
RSRenato Hideo Nakagawa Santos
Renato Hideo Nakagawa Santos
ANAntonio Paulo Nassar
Antonio Paulo Nassar
TVThabata Silva Veiga
Thabata Silva Veiga
ACAlexandre Biasi Cavalcanti
Alexandre Biasi Cavalcanti
Limited data is available to evaluate the burden of device associated healthcare infections (HAI) [central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and ventilator associated pneumonia (VAP)] in low and-middle-income countries. Our aim is to investigate the population attributable mortality fraction and the absolute mortality difference of HAI in a broad population of critically ill patients from Brazil. Multicenter cohort study from September 2019 to December 2023 with prospective individual patient data collection. VAP, CLABSI, and CAUTI were diagnosed by each center in accordance with Brazilian regulatory agency guidance. If a patient fulfilled all diagnostic criteria, he was deemed to have Confirmed HAI. An adjusted disability multistate model was used to evaluate the population attributable in-hospital mortality fraction (PAF) and the absolute in-hospital mortality difference (AMD). A total of 128,247 patients were included. 4066 (3.2%) distinct patients had at least one diagnosis of HAI (1493 CLABSI, 433 CAUTI, 2742 VAP, and 435 patients with more than one HAI) during the ICU stay. The PAF was 3.89% (95% CI 3.68–4.11%) for HAI, 2.16% (2.05–2.33%) for VAP, 1.2% (1.08–1.32%) for CLABSI, 0.11% (0.07–0.16%) for CAUTI, and 0.33% (0.26–0.4%) for ≥ 2 HAI. The AMD for HAI was 33.69% (95% CI 32.27–35.33%), 29.01% (27.15–30.98%) for VAP, 31.64% (29.3–34.81%) for CLABSI, 9.94% (3.88–15.54%) for CAUTI and 35.6% (28.93–42.99%) for ≥ 2 HAI. Device-associated HAI significantly contribute to hospital mortality and impose a high excess risk of death for critically ill patients.

1 May 2020 in Medicine
Verified
Journal Article
Open access
VSVicente Cés Souza-Dantas
Vicente Cés Souza-Dantas
FDFelipe Dal-Pizzol
Felipe Dal-Pizzol
CTCristiane D. Tomasi
Cristiane D. Tomasi
NSNelson Spector
Nelson Spector
MSMarcio Soares
Marcio Soares
JSJorge I. F. Salluh
Jorge I. F. Salluh
Acute brain dysfunction (ABD) is a frequent and severe syndrome occurring in critically ill patients and early identification of high-risk patients is paramount. In the present analysis, we propose a clinically applicable model for early phenotype identification of ABD at the bedside in mechanically ventilated patients, improving the recognition of patients with prolonged ABD. Prospective cohort with 629 mechanically ventilated patients in two medical-surgical intensive care units at academic centers. We applied cluster analysis to identify phenotypes using clinical and biological data. We then tested the association of phenotypes and its respective clinical outcomes. We performed a validation on a new cohort of patients select on subsequent patients admitted to the participants intensive care units. A model with 3 phenotypes best described the study population. A 4-variable model including medical admission, sepsis diagnosis, simplified acute physiologic score II and basal serum C-reactive protein (CRP) accurately classified each phenotype (area under curve 0.82; 95% CI, 0.79–0.86). Phenotype A had the shorter duration of ABD (median, 1 day), while phenotypes B and C had progressively longer duration of ABD (median, 3 and 6 days, respectively; P < .0001). There was an association between the duration of ABD and the baseline CRP levels and simplified acute physiology score II score (sensitivity and specificity of 80%). To increase the sensitivity of the model, we added CRP kinetics. By day 1, a CRP < 1.0 times the initial level was associated with a shorter duration of ABD (specificity 0.98). A model based on widely available clinical variables could provide phenotypes associated with the duration of ABD. Phenotypes with longer duration of ABD (phenotypes B and C) are characterized by more severe inflammation and by significantly worse clinical outcomes.

3 June 2016 in Hospital Practice
Verified
Journal Article
Closed access
VSVicente Cés Souza-Dantas
Vicente Cés Souza-Dantas
PPPedro Póvoa
Pedro Póvoa
FBFernando Bozza
Fernando Bozza
MSMarcio Soares
Marcio Soares
JSJorge Salluh
Jorge Salluh
Delirium is the most frequent and severe clinical presentation of brain dysfunction in critically ill septic patients with an incidence ranging from 9% to 71%. Delirium represents a significant burden for patients and relatives, as well as to the health care system, resulting in higher costs, long-term cognitive impairment and significant risk of death after 6 months. Current interventions for the prevention of delirium typically involve early recognition and amelioration of modifiable risk factors and treatment of underlying conditions that predisposes the individual to delirium. Several pharmacological interventions to prevent and treat delirium have been tested, although their effectiveness remains uncertain, especially in larger and more homogeneous subgroups of ICU patients, like in patients with sepsis. To date, there is inconsistent and conflicting data regarding the efficacy of any particular pharmacological agent, thus substantial attention has been paid to non-pharmacological interventions and preventive strategies should be applied to every patient admitted in the ICU. Future trials should be designed to evaluate the impact of these pharmacologic interventions on the prevention and treatment of delirium on clinically relevant outcomes such as length of stay, hospital mortality and long-term cognitive function. The role of specific medications like statins in delirium prevention is also yet to be evaluated.

1 January 2023 in Critical Care Science
Verified
Journal Article
Open access
PDF file
LRLuciana Leal Do Rego
Luciana Leal Do Rego
JSJorge I. F. Salluh
Jorge I. F. Salluh
VSVicente Cés Souza-Dantas
Vicente Cés Souza-Dantas
JSJOSE R. LAPA E SILVA
JOSE R. LAPA E SILVA
PPPedro Póvoa
Pedro Póvoa
RSRodrigo Serafim
Rodrigo Serafim
To investigate the impact of delirium severity in critically ill COVID-19 patients and its association with outcomes. This prospective cohort study was performed in two tertiary intensive care units in Rio de Janeiro, Brazil. COVID-19 patients were evaluated daily during the first 7 days of intensive care unit stay using the Richmond Agitation Sedation Scale, Confusion Assessment Method for Intensive Care Unit (CAM-ICU) and Confusion Method Assessment for Intensive Care Unit-7 (CAM-ICU-7). Delirium severity was correlated with outcomes and one-year mortality. Among the 277 COVID-19 patients included, delirium occurred in 101 (36.5%) during the first 7 days of intensive care unit stay, and it was associated with a higher length of intensive care unit stay in days (IQR 13 [7 - 25] versus 6 [4 - 12]; p < 0.001), higher hospital mortality (25.74% versus 5.11%; p < 0.001) and additional higher one-year mortality (5.3% versus 0.6%, p < 0.001). Delirium was classified by CAM-ICU-7 in terms of severity, and higher scores were associated with higher in-hospital mortality (17.86% versus 34.38% versus 38.46%, 95%CI, p value < 0.001). Severe delirium was associated with a higher risk of progression to coma (OR 7.1; 95%CI 1.9 - 31.0; p = 0.005) and to mechanical ventilation (OR 11.09; 95%CI 2.8 - 58.5; p = 0.002) in the multivariate analysis, adjusted by severity and frailty. In patients admitted with COVID-19 in the intensive care unit, delirium was an independent risk factor for the worst prognosis, including mortality. The delirium severity assessed by the CAM-ICU-7 during the first week in the intensive care unit was associated with poor outcomes, including progression to coma and to mechanical ventilation.